{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:00:42Z","timestamp":1778551242791,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","award":["MOP# 142773"],"award-info":[{"award-number":["MOP# 142773"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.coph.2015.09.002","type":"journal-article","created":{"date-parts":[[2015,9,27]],"date-time":"2015-09-27T07:03:18Z","timestamp":1443337398000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Pharmacological approaches in celiac disease"],"prefix":"10.1016","volume":"25","author":[{"given":"Justin L","family":"McCarville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Caminero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena F","family":"Verdu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2015.09.002_bib0300","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1056\/NEJMoa1313977","article-title":"Risk of pediatric celiac disease according to HLA haplotype and country","volume":"371","author":"Liu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2015.09.002_bib0305","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.immunol.18.1.53","article-title":"Molecular basis of celiac disease","volume":"18","author":"Sollid","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coph.2015.09.002_bib0310","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/73200","article-title":"In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope","volume":"6","author":"Anderson","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2015.09.002_bib0315","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nm.2656","article-title":"High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions","volume":"18","author":"Di Niro","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2015.09.002_bib0320","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00281-012-0316-x","article-title":"Intraepithelial lymphocytes in celiac disease immunopathology","volume":"34","author":"Abadie","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.coph.2015.09.002_bib0325","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/imr.12191","article-title":"IL-15: a central regulator of celiac disease immunopathology","volume":"260","author":"Abadie","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coph.2015.09.002_bib0330","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2013.12.023","article-title":"Interleukin 15 and CD4(+) T cells cooperate to promote small intestinal enteropathy in response to dietary antigen","volume":"146","author":"Korneychuk","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2015.09.002_bib0335","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ajg.2010.10","article-title":"Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet","volume":"105","author":"Rubio-Tapia","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2015.09.002_bib0340","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cgh.2006.12.006","article-title":"Etiologies and predictors of diagnosis in nonresponsive celiac disease","volume":"5","author":"Leffler","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2015.09.002_bib0345","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1586\/17474124.2014.876360","article-title":"Nutritional consequences of celiac disease and the gluten-free diet","volume":"8","author":"Theethira","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2015.09.002_bib0350","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.appet.2013.04.016","article-title":"Intentional and inadvertent non-adherence in adult coeliac disease. A cross-sectional survey","volume":"68","author":"Hall","year":"2013","journal-title":"Appetite"},{"key":"10.1016\/j.coph.2015.09.002_bib0355","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/j.1572-0241.2002.05917.x","article-title":"Etiology of nonresponsive celiac disease: results of a systematic approach","volume":"97","author":"Abdulkarim","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2015.09.002_bib0360","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1126\/science.1074129","article-title":"Structural basis for gluten intolerance in celiac sprue","volume":"297","author":"Shan","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.coph.2015.09.002_bib0365","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/B978-0-12-416039-2.00013-6","article-title":"Oral enzyme therapy for celiac sprue","volume":"502","author":"Bethune","year":"2012","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.coph.2015.09.002_bib0370","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/gut.2006.111609","article-title":"Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease","volume":"57","author":"Mitea","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.coph.2015.09.002_bib0375","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.3748\/wjg.v19.i35.5837","article-title":"Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study","volume":"19","author":"Tack","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coph.2015.09.002_bib0380","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clim.2009.11.001","article-title":"The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo","volume":"134","author":"Tye-Din","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coph.2015.09.002_bib0385","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/j.gastro.2007.05.028","article-title":"Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue","volume":"133","author":"Gass","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2015.09.002_sbref0390","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease","volume":"146","author":"Lahdeaho","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2015.09.002_bib0395","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/gastro\/gov006","article-title":"Development of drugs for celiac disease: review of endpoints for Phase 2 and 3 trials","volume":"3","author":"Gottlieb","year":"2015","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.coph.2015.09.002_bib0400","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2011.08.030","article-title":"Non-dietary therapeutic clinical trials in coeliac disease","volume":"23","author":"Crespo Perez","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.coph.2015.09.002_bib0405","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/j.gastro.2008.09.016","article-title":"Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium","volume":"136","author":"Pinier","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2015.09.002_bib0410","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.gastro.2011.10.038","article-title":"The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues","volume":"142","author":"Pinier","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2015.09.002_sbref0415","doi-asserted-by":"crossref","first-page":"e109972","DOI":"10.1371\/journal.pone.0109972","article-title":"BL-7010 demonstrates specific binding to gliadin and reduces gluten-associated pathology in a chronic mouse model of gliadin sensitivity","volume":"9","author":"McCarville","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coph.2015.09.002_bib0420","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2249.2010.04317.x","article-title":"Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A","volume":"164","author":"Rauhavirta","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coph.2015.09.002_bib0425","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1053\/j.gastro.2012.05.051","article-title":"Interactions among secretory immunoglobulin A CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides","volume":"143","author":"Lebreton","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2015.09.002_bib0430","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2008.03.023","article-title":"Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3","volume":"135","author":"Lammers","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2015.09.002_bib0435","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.peptides.2012.02.016","article-title":"Larazotide acetate promotes tight junction assembly in epithelial cells","volume":"35","author":"Gopalakrishnan","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.coph.2015.09.002_sbref0440","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.02.008","article-title":"Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial","author":"Leffler","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2015.09.002_bib0445","doi-asserted-by":"crossref","first-page":"e30642","DOI":"10.1371\/journal.pone.0030642","article-title":"Activation and inhibition of transglutaminase 2 in mice","volume":"7","author":"Dafik","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coph.2015.09.002_bib0450","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s10875-012-9745-5","article-title":"Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study","volume":"33","author":"Rauhavirta","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coph.2015.09.002_bib0455","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.bmc.2007.10.091","article-title":"Design of azidoproline containing gluten peptides to suppress CD4+ T-cell responses associated with celiac disease","volume":"16","author":"Kapoerchan","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.coph.2015.09.002_bib0460","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1016\/j.bmc.2007.07.001","article-title":"Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease","volume":"15","author":"Xia","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.coph.2015.09.002_bib0465","first-page":"119","article-title":"CCR9 antagonism: potential in the treatment of inflammatory bowel disease","volume":"8","author":"Wendt","year":"2015","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.coph.2015.09.002_bib0470","doi-asserted-by":"crossref","first-page":"e60094","DOI":"10.1371\/journal.pone.0060094","article-title":"A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease","volume":"8","author":"Keshav","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coph.2015.09.002_bib0475","doi-asserted-by":"crossref","first-page":"41ra51","DOI":"10.1126\/scitranslmed.3001012","article-title":"Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease","volume":"2","author":"Tye-Din","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coph.2015.09.002_bib0480","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1182\/blood-2012-08-450585","article-title":"Phase 1 trial of IL-15 trans presentation blockade using humanized Mikbeta1 mAb in patients with T-cell large granular lymphocytic leukemia","volume":"121","author":"Waldmann","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.coph.2015.09.002_bib0485","doi-asserted-by":"crossref","first-page":"15849","DOI":"10.1073\/pnas.0908834106","article-title":"Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes","volume":"106","author":"Yokoyama","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2015.09.002_bib0490","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1172\/JCI41344","article-title":"IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis","volume":"120","author":"Malamut","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coph.2015.09.002_bib0495","doi-asserted-by":"crossref","first-page":"30433","DOI":"10.1074\/jbc.R800035200","article-title":"Proteases: multifunctional enzymes in life and disease","volume":"283","author":"Lopez-Otin","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2015.09.002_bib0500","doi-asserted-by":"crossref","first-page":"158ra144","DOI":"10.1126\/scitranslmed.3004212","article-title":"Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis","volume":"4","author":"Motta","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coph.2015.09.002_sbref0505","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/ajg.2014.48","article-title":"Novel role of the serine protease inhibitor elafin in gluten-related disorders","volume":"109","author":"Galipeau","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2015.09.002_bib0510","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2180-10-63","article-title":"Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children","volume":"10","author":"De Palma","year":"2010","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.coph.2015.09.002_bib0515","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2014.355","article-title":"Altered duodenal microbiota composition in celiac disease patients suffering from persistent symptoms on a long-term gluten-free diet","author":"Wacklin","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2015.09.002_bib0520","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(15)30097-4","article-title":"Widespread contamination of probiotics with gluten, detected by liquid chromatography\u2013mass spectrometry","author":"Nazareth","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2015.09.002_bib0525","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbadis.2005.09.008","article-title":"VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue","volume":"1762","author":"De Angelis","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.coph.2015.09.002_bib0530","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2249.2008.03635.x","article-title":"Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture","volume":"152","author":"Lindfors","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coph.2015.09.002_bib0535","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-3083.2011.02582.x","article-title":"Immunomodulatory effects of Lactobacillus casei administration in a mouse model of gliadin-sensitive enteropathy","volume":"74","author":"D\u2019Arienzo","year":"2011","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.coph.2015.09.002_sbref0540","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MCG.0b013e31827759ac","article-title":"Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease","volume":"47","author":"Smecuol","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.coph.2015.09.002_bib0545","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S0007114514000609","article-title":"Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease","volume":"112","author":"Olivares","year":"2014","journal-title":"Br J Nutr"},{"key":"10.1016\/j.coph.2015.09.002_bib0550","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/1574-6941.12295","article-title":"Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease","volume":"88","author":"Caminero","year":"2014","journal-title":"FEMS Microbiol Ecol"},{"key":"10.1016\/j.coph.2015.09.002_bib0555","doi-asserted-by":"crossref","first-page":"E386","DOI":"10.1111\/1469-0691.12249","article-title":"The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity","volume":"19","author":"Fernandez-Feo","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.coph.2015.09.002_bib0560","doi-asserted-by":"crossref","first-page":"G769","DOI":"10.1152\/ajpgi.00144.2014","article-title":"Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease","volume":"307","author":"Tian","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2015.09.002_bib0565","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2015.97","article-title":"Identification of pseudolysin (lasB) as an aciduric gluten-degrading enzyme with high therapeutic potential for celiac disease","author":"Wei","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2015.09.002_bib0570","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12865-015-0074-3","article-title":"Human helminth therapy to treat inflammatory disorders\u2014where do we stand?","volume":"16","author":"Helmby","year":"2015","journal-title":"BMC Immunol"},{"key":"10.1016\/j.coph.2015.09.002_bib0575","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijpara.2012.12.005","article-title":"Changed gluten immunity in celiac disease by Necator americanus provides new insights into autoimmunity","volume":"43","author":"Croese","year":"2013","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.coph.2015.09.002_bib0580","doi-asserted-by":"crossref","first-page":"e24092","DOI":"10.1371\/journal.pone.0024092","article-title":"Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection","volume":"6","author":"McSorley","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coph.2015.09.002_bib0585","doi-asserted-by":"crossref","first-page":"e17366","DOI":"10.1371\/journal.pone.0017366","article-title":"Effect of hookworm infection on wheat challenge in celiac disease\u2014a randomised double-blinded placebo controlled trial","volume":"6","author":"Daveson","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coph.2015.09.002_sbref0590","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jaci.2014.07.022","article-title":"Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease","volume":"135","author":"Croese","year":"2015","journal-title":"J Allergy Clin Immunol"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489215001046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489215001046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T04:53:16Z","timestamp":1537332796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489215001046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":59,"alternative-id":["S1471489215001046"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2015.09.002","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological approaches in celiac disease","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2015.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}